Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Immunologic Function in the Elderly After Injury

This study has been completed.
Information provided by:
Summa Health System Identifier:
First received: August 7, 2006
Last updated: January 28, 2008
Last verified: January 2008
The purpose of this research is to learn more about the function of the body's ability to fight infection when the immune response is activated when injury occurs, in the elderly population.

Over the Age of 65
Admitted to the Trauma Service

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Immunologic Function in the Elderly After Injury: the Polymorphonuclear Leukocyte (PMN) and Innate Immunity

Further study details as provided by Summa Health System:

Enrollment: 55
Study Start Date: March 2005
Study Completion Date: December 2005
Primary Completion Date: December 2005 (Final data collection date for primary outcome measure)
  Show Detailed Description


Ages Eligible for Study:   66 Years and older   (Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Elderly after injury

Inclusion Criteria:

  • Greater than 65
  • Admitted to the trauma service

Exclusion Criteria:

  • Inability to draw sufficient blood
  • Immunocompromised
  • Currently receiving systemic corticosteroids
  • Participation in other studies
  • In the opinion of the investigator will not be able to complete protocol
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00447135

United States, Ohio
Summa Health System
Akron, Ohio, United States, 44304
Sponsors and Collaborators
Summa Health System
Principal Investigator: William Fallon, MD Summa Health System
  More Information

Responsible Party: Dr. William Fallon, Summa Health System Identifier: NCT00447135     History of Changes
Other Study ID Numbers: 04104
Study First Received: August 7, 2006
Last Updated: January 28, 2008

Keywords provided by Summa Health System:
Polymorphonuclear Leukocyte
Immunity processed this record on April 25, 2017